Review Article
The Association of Metabolic Syndrome and Urolithiasis
Table 3
ABCDE approach to managing metabolic syndrome [
52].
| A | Aspirin | | All patients with > 6% 10 year risk (without contraindications) |
| B | Blood pressure control | Goal | <130/80 mmHg if at intermediate risk (>6% 10 year risk) | First line | ACEI or ACE | Alternatives | -blocker or diuretics may increase risk of diabetes |
| C | Cholesterol management | | | LDL-C | Goal | <130 mg/dL if at intermediate risk <100 mg/dL if at high risk | First line | Statins | Non-HDL-C | Goal | <160 mg/dL if at intermediate risk <130 mg/dL if at high risk | First line | Statins, fenofibrate | Alternatives | Omega-3 fatty acid supplement | HDL-C | | Long acting niacin may increase risk of glucose intolerance |
| D | Diabetes prevention | First line | Lifestyle modification | Second line | Metformin, pioglitazone | Diet | | Weight loss, low glycemic load |
| E | Exercise | | Daily moderate to rigorous exercise Recommend use of pedometer with goal of >10000 steps/day |
|
|